Literature DB >> 36136146

Monitoring of Soluble Forms of BAFF System (BAFF, APRIL, sR-BAFF, sTACI and sBCMA) in Kidney Transplantation.

Isabel Legaz1, Manuel Muro2, Rafael Alfaro3, Santiago Llorente4, Pedro Martinez3, Víctor Jimenez-Coll3, Helios Martínez-Banaclocha3, José Antonio Galián3, Carmen Botella3, María Rosa Moya-Quiles3, Jesús de la Peña-Moral5, Alfredo Minguela3.   

Abstract

BAFF system plays an essential role in B cells homeostasis and tolerance, although it has widely not been tested in transplantation with doubtful results. The main purpose was to study the BAFF soluble forms and their correlation with acute rejection (AR) and donor-specific antibodies production. Serum levels of BAFF, APRIL, and soluble forms of their receptors were analyzed in renal recipients with and without acute rejection (AR/NAR) appearance. All molecules were evaluated at pre- and post-transplantation. sTACI showed a significant correlation with BAFF and sR-BAFF levels, and sBCMA also showed a positive correlation with sAPRIL levels. A significant increase in sAPRIL levels in patients suffering AR was also found, and ROC curves analysis showed an AUC = 0.724, a concentration of 6.05 ng/ml (sensitivity: 66.7%; specificity: 73.3%), the best cutoff point for predicting AR. In the post-transplant dynamics of sAPRIL levels in the longitudinal cohort, we observed a significant decrease at 3 and 6 month post-transplantation compared to pretransplantation status. We also observed that recipients with high pre-transplant levels of sAPRIL generated antibodies earlier than those with lower sAPRIL levels, although their long-term post-transplantation was not different. Our results show that elevated serum levels of APRIL may be helpful as a biomarker for the diagnosis of AR, although the longitudinal study shows that it is not helpful as a prognostic biomarker.
© 2022. L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.

Entities:  

Keywords:  Acute rejection; BAFF system soluble forms; Forensic medicine; Kidney transplant

Year:  2022        PMID: 36136146     DOI: 10.1007/s00005-022-00659-4

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   3.831


  38 in total

Review 1.  BAFF, APRIL and their receptors: structure, function and signaling.

Authors:  Claudia Bossen; Pascal Schneider
Journal:  Semin Immunol       Date:  2006-08-17       Impact factor: 11.130

2.  Blockade of BAFF Receptor BR3 on T Cells Enhances Their Activation and Cytotoxicity.

Authors:  Debra D Bloom; Sofiya Reshetylo; Cassandra Nytes; Claudia T Goodsett; Peiman Hematti
Journal:  J Immunother       Date:  2018-06       Impact factor: 4.456

3.  APRIL levels are associated with disease activity in human chronic graft-versus-host disease.

Authors:  François Chasset; Adèle de Masson; Hélène Le Buanec; Aliénor Xhaard; Flore Sicre de Fontbrune; Marie Robin; Michel Rybojad; Nathalie Parquet; Anne C Brignier; Tereza Coman; Djaouida Bengoufa; Anne Bergeron; Régis Peffault de Latour; Martine Bagot; Armand Bensussan; Gérard Socié; Jean-David Bouaziz
Journal:  Haematologica       Date:  2016-03-18       Impact factor: 9.941

Review 4.  The function of BAFF on T helper cells in autoimmunity.

Authors:  Maogen Chen; Xiaohong Lin; Ya Liu; Qiang Li; Yiling Deng; Zhongmin Liu; David Brand; Zhiyong Guo; Xiaoshun He; Bernhard Ryffel; Song Guo Zheng
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-24       Impact factor: 7.638

5.  Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD.

Authors:  William B Clark; Kristin D Brown-Gentry; Dana C Crawford; Kang-Hsien Fan; Jennifer Snavely; Heidi Chen; Bipin N Savani; Adetola Kassim; John P Greer; Friedrich G Schuening; Brian G Engelhardt; Madan H Jagasia
Journal:  Blood       Date:  2011-05-31       Impact factor: 22.113

6.  Personalized Medicine for Kidney Transplantation: Association of Graft Survival and Acute Transplant Rejection with Genetic Variation in B Cell Activating Factor System Signaling.

Authors:  Rafael Alfaro; El Kaaoui El Band Jaouad; Santiago Llorente; Victor Jimenez-Coll; Helios Martínez-Banaclocha; José Antonio Galián; Carmen Botella; María Rosa Moya-Quiles; Jesús de la Peña-Moral; Alfredo Minguela; Isabel Legaz; Manuel Muro
Journal:  OMICS       Date:  2021-10-29

7.  Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL.

Authors:  Micah J Benson; Stacey R Dillon; Emanuela Castigli; Raif S Geha; Shengli Xu; Kong-Peng Lam; Randolph J Noelle
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

8.  Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection.

Authors:  Shima Afzali; Saeedeh Salehi; Abbas Shahi; Marzie Esmaeili; Samad Farashi Bonab; Azin Peykari; Farzaneh Bagherpour; Bita Ansaripour; Tayebeh Soleimanian; Fatemeh Pour-Reza-Gholi; Aliakbar Amirzargar
Journal:  J Immunol Res       Date:  2021-03-06       Impact factor: 4.818

9.  Monitoring of B Cell in Kidney Transplantation: Development of a Novel Clusters Analysis and Role of Transitional B Cells in Transplant Outcome.

Authors:  Rafael Alfaro; Isabel Legaz; Gema González-Martínez; Víctor Jimenez-Coll; Helios Martínez-Banaclocha; José Antonio Galián; Carmen Botella; Jesús de la Peña-Moral; María Rosa Moya-Quiles; José Antonio Campillo; Alfredo Minguela; Santiago Llorente; Manuel Muro
Journal:  Diagnostics (Basel)       Date:  2021-04-01

10.  MicroRNA Expression Changes in Kidney Transplant: Diagnostic Efficacy of miR-150-5p as Potential Rejection Biomarker, Pilot Study.

Authors:  Rafael Alfaro; Isabel Legaz; Victor Jimenez-Coll; Jaouad El Kaaoui El Band; Helios Martínez-Banaclocha; José Antonio Galián; Antonio Parrado; Anna Mrowiec; Carmen Botella; María Rosa Moya-Quiles; Francisco Boix; Jesús de la Peña-Moral; Alfredo Minguela; Santiago Llorente; Manuel Muro
Journal:  J Clin Med       Date:  2021-06-22       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.